Clinical Trials Logo

Acute Wound clinical trials

View clinical trials related to Acute Wound.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04884568 Completed - Acute Wound Clinical Trials

Confirm Performance and Safety of Exufiber When Used as Intended on Donor Sites

ExuDS01
Start date: November 16, 2021
Phase: N/A
Study type: Interventional

This is a single-centre prospective, open, non-comparative, Post-Market Clinical Follow-up (PMCF) investigation to confirm performance and safety of Exufiber® (Gelling fibre dressing) when used as intended on donor sites through assessment of wound progression from baseline to the subject´s last visit.

NCT ID: NCT04754048 Completed - Skin Graft Clinical Trials

Confirm the Safety and Performance of Avance Solo NPWT System

ASOLO-SW
Start date: June 15, 2021
Phase: N/A
Study type: Interventional

The primary objective of this post market clinical follow-up (PMCF) investigation is to confirm safety and performance of Avance® Solo NPWT System in low to moderate exuding acute (traumatic wounds and flaps and grafts), as well as subacute (e.g., dehisced wounds) wounds when used in accordance with the Instructions for Use, for up to 28 days.

NCT ID: NCT04593693 Completed - Diabetic Foot Ulcer Clinical Trials

A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System

Start date: December 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.

NCT ID: NCT02417818 Completed - Burn Injury Clinical Trials

Cutaneous Microcirculation After Plasma Therapy

Start date: March 2015
Phase: N/A
Study type: Interventional

In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that Plasma Therapy can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of Plasma Therapy on second-degree burns, superficial wounds, burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.

NCT ID: NCT02417805 Completed - Burn Injury Clinical Trials

Cutaneous Microcirculation After Remote Ischemic Preconditioning

Start date: March 2015
Phase: N/A
Study type: Interventional

In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that remote ischemic preconditioning (RIPC) can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of remote ischemic preconditioning on second-degree burns, superficial and chronic wounds in a human in-vivo setting for the first time.

NCT ID: NCT02417779 Completed - Burn Injury Clinical Trials

Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy

Start date: March 2015
Phase: N/A
Study type: Interventional

In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that extracorporeal shock wave therapy (ESWT) can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of extracorporeal shock wave therapy on second-degree burns, superficial wounds, hypertrophic burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.